Dernières nouvelles pour Intchains Gr (NASDAQ:ICG) Stock

Intchains Gr

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Earnings

News

YSXT

YSX TECH. CO. 2025 Total Revenue $71.5M, Up 22%

Natuzzi S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTZ#NYSE">NTZ</a>) ("Natuzzi" or the "Company") announced today that Mr. Antonio Achille, who has served as the Company's Chief Executive Officer and executive director since 2021, stepped down from his roles effective July 30, 2025, to pursue new professional opportunities.
Pending the appointment of a successor, the Board of Directors has temporarily delegated the CEO's powers and responsibilities to the Executive Chairman, Mr. Pasquale Natuzzi, who will serve in an interim capacity.

Management

Natuzzi CEO Antonio Achille Resigns, Effective July 30, 2025; Board Temporarily Delegates CEO's Responsibilities To Executive Chairman, Pasquale Natuzzi

RBOT

Vicarious Surgical Appoints Stephen From As CEO

Azenta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZTA#NASDAQ">AZTA</a>) today announced that it has entered a collaboration with&nbsp;Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin genomic sequencing and data generation for Frenova's transformative MyReason&#xAE; genomics research program. This strategic collaboration aims to leverage cutting-edge technologies to enhance the understanding of cardio-kidney-metabolic diseases and drive advancements in precision medicine for patients worldwide.
The MyReason research program is an innovative initiative designed to uncover insights into the genetic mechanisms underlying kidney disease. To date, more than 35,000 participants have been registered in the program and provided biospecimens, with a goal of reaching 50,000 participants over the next two years.
Nephronomics holds exclusive commercial rights to the MyReason dataset, which anchors the Nephronomics Atlas, an unparalleled resource of deep clinical and genomic cardio-kidney-metabolic (CKM) disease data. Nephronomics aims to develop targeted therapies and redefine CKM disease care through precision medicine insights. By leveraging proprietary artificial intelligence (AI)/machine learning (ML) models trained on this comprehensive dataset, Nephronomics identifies novel disease subtypes, protective genetic variants, and therapeutic targets.
Azenta will support the collaboration by delivering genomic sequencing through GENEWIZ and managing long-term sample storage within its global biorepository network. With decades of experience in multiomics analysis and sample management solutions, Azenta is uniquely positioned to provide end-to-end solutions for complex research programs.

Biotech

General

AZTA

Azenta Joins Frenova And Nephronomics To Power MyReason Genomics Program Aiming To Transform Precision CKM Disease Care

FBLG

FibroBiologics H1 2025 Net Loss ~$9.6M

BWXT

BWX Technologies Appoints Mike Fitzgerald As CFO

Gray Media has reached an agreement to acquire SagamoreHill Broadcasting's WLTZ, the NBC affiliate for the Columbus, Georgia, market (DMA 127), and KJTV, the FOX affiliate for the Lubbock, Texas, market (DMA 140). For the past several years, Gray has provided back-office services to both stations through its Columbus ABC affiliate WTVM and its Lubbock NBC affiliate KCBD, respectively.
Gray anticipates closing these transactions in the fourth quarter of this year following receipt of regulatory approval and other customary closing conditions. In that regard, Gray will request waivers of the FCC's current local broadcast ownership rule under the same "failing station" waiver standard through which the FCC has authorized similar combinations over the past 25 years, including earlier this year in connection with Gray's acquisition from SagamoreHill Broadcasting of KXLT, the FOX affiliated television station in the Rochester, Minnesota, market.

Gray Media Announces Agreement To Acquire SagamoreHill Broadcasting's Columbus , Georgia NBC Affiliate ALTZ And Lubbock, Texas Fox Affiliate KJTV, The Fox Affiliate For The Lubbock, Texas; Terms Not Disclosed

RARE

Ultragenyx Completes Enrollment In Its Phase 3 Aspire Study Of Apazunersen For Angelman Syndrome

Excelerate Energy, Inc. (the "Company" or "Excelerate") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) announced today that its Board of Directors has declared a quarterly cash dividend, with respect to the quarter ended June 30, 2025, of $0.08 per share of Class A common stock, representing an approximately 33% increase from the prior quarter. The dividend is payable on September 4, 2025, to Class A common stockholders of record as of the close of business on August 20, 2025.

Dividends

Excelerate Energy Raises Quarterly Dividend By 33% From $0.06/Share To $0.08

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading global agricultural sciences company, today announced it has received registration for Fundatis&#xAE; herbicide powered by Isoflex&#xAE; active in Great Britain for use in winter wheat and winter barley. Isoflex&#xAE; active is a novel herbicide when used in cereals and is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. Fundatis&#xAE; herbicide provides growers with a new tool to help manage herbicide resistance across a wide range of agronomic practices.

FMC Corp. Receives Registration For Fundatis Herbicide Powered By Isoflex Active In Great Britain For Use In Winter Wheat And Winter Barley

INCY

Knight Therapeutics Submitted Supplemental Application To ANVISA For Approval Of Additional Indication For MINJUVI

WIIM

Clorox shares are trading higher after the company reported better-than-expected Q4 adjusted EPS and sales.

Strategic acquisition jumpstarts WisdomTree's entry into the private asset markets, with a focus on a high-growth $3.5 trillion U.S. farmland market and adjacent verticals, including solar, AI data infrastructure and water
Day 1 accretive transaction that accelerates long-term earnings growth potential
WisdomTree, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>), a global financial innovator, announced today that it entered into a definitive agreement to acquire Ceres Partners, LLC, a leading U.S.-based alternative asset manager specializing in farmland investments. This transaction marks WisdomTree's entry into the private asset markets—starting with real estate and specifically farmland—and positions WisdomTree as a category leader. Additionally, the Ceres farmland platform benefits from opportunities in strategic adjacencies in demand for solar, AI data infrastructure and water that are expected to drive faster growth.
The acquisition delivers immediate scale and long-term upside, bringing approximately $1.85 billion in assets under management across approximately 545 U.S. farmland properties spanning 12 states, predominantly in the Midwest. Ceres has a strong track record of performance, having delivered a 10.3% net average annual total return since its inception in 2007—outperforming farmland benchmarks.
With farmland recognized as one of the largest and most underpenetrated real asset classes in the U.S., WisdomTree believes there is significant opportunity for growth. The asset class historically provides resilient, inflation-protected returns and is largely uncorrelated to traditional equity and bond markets. As demand accelerates for income-generating, inflation-hedged private investments, this transaction well positions WisdomTree to offer differentiated access on an institutional scale. Farmland prices and asset values rose in the U.S. in all but nine years since World War II, and Ceres represents a value-added platform in a category that has the fundamentals for greater advisor and institutional adoption.
"Farmland is one of the largest yet most underpenetrated real asset classes in the U.S., offering both scale and scarcity," said Jonathan Steinberg, WisdomTree Founder and CEO. "This acquisition expands our leadership in innovative, income-generating investment solutions, while strategically accelerating our entry into private asset markets with a high-quality, scalable platform. It reflects our commitment to delivering differentiated exposures that drive long-term value for clients and stockholders alike. This strategic acquisition now positions WisdomTree to capitalize on the most significant structural growth opportunities in wealth and asset management today: ETPs, private markets, managed models and tokenization."
Perry Vieth, Founder and CEO, Ceres Partners, said, "We are proud of Ceres' long-standing partnerships and legacy with farmers. Joining forces with WisdomTree marks an exciting new chapter for Ceres. For nearly two decades, we've built a differentiated farmland investment platform rooted in performance, operational expertise and a deep understanding of U.S. agricultural markets. This partnership brings product innovation, scale and distribution that will allow us to reach more investors seeking resilient, inflation-hedged and income-generating real assets. Together, we are uniquely positioned to capitalize on the next wave of growth in farmland —including solar, AI data infrastructure and water—with a shared commitment to innovation and long-term value creation."

WisdomTree Announces Acquisition Of Ceres Partners; Terms Not Disclosed

COIN

Coinbase shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS and sales.

Boise Cascade Increases Quarterly Dividend From $0.21 To $0.22

LGND

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

Orchestra BioMed Secures  $70M In New Capital From Ligand Pharmaceuticals And Medtronic To Advance Its Late-Stage Partnered Cardiology Programs

SR Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRBK#NASDAQ">SRBK</a>) reported quarterly earnings of $0.10 per share. The company reported $7.500 million in sales this quarter.

SRBK

SR Bancorp Q4 EPS $0.10, Sales $7.500M

AVNS

Avanos Medical Divests Hyaluronic Acid Product Line To Channel-Markers Medical; Avanos To Provide Transition Support Through 2025 End

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) raises FY2025 GAAP EPS guidance from $(1.07)-$(1.00) to $(0.79)-$(0.72) vs $(1.03) analyst estimate..

Guidance

Workiva Raises FY2025 GAAP EPS Guidance from $(1.07)-$(1.00) to $(0.79)-$(0.72) vs $(1.03) Est

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) raises FY2025 Adj EPS guidance from $1.02-$1.09 to $1.31-$1.38 vs $1.04 analyst estimate. Raises FY2025 sales outlook from $864.000 million-$868.000 million to $870.000 million-$873.000 million vs $866.326 million estimate.

Workiva Raises FY2025 Adj EPS Guidance from $1.02-$1.09 to $1.31-$1.38 vs $1.04 Est; Raises FY2025 Sales Guidance from $864.000M-$868.000M to $870.000M-$873.000M vs $866.326M Est

Press Releases

Intchains Group Limited Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

Intchains Group Limited's Goldshell launches its first ever crypto wallet today: GS Wallet brings users next-gen security and premium user experience

Intchains Group Limited Announces Entry into Agreement for Registered Direct Offering of its ADSs and Warrants

Intchains Group Limited's Goldshell launches its innovative product today: Goldshell Byte enables dual mining with swappable cards

Financing

Intchains Group Limited Announces Closing of Registered Direct Offering of its ADSs and Warrants

Intchains Group Limited to Report Unaudited First Quarter 2025 Financial Results on Thursday, May 22, 2025

Intchains Group Limited to Participate in the "Virtual Digital Assets Seminar" Presented by Benchmark Company on Tuesday, May 20th at 9:45 a.m. EDT

Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results

Intchains Group Limited to Report Second Quarter 2025 Financial Results on Thursday, August 14

Intchains Expands Collaboration with FalconX to Optimize ETH Acquisition and Enhance Yield

Blaize Holdings

CEVA

Datavault AI

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Intchains Group Limited - American Depositary Shares

ChipMOS TECHNOLOGIES INC. - American Depositary Shares

ChipMOS TECHNOLOGIES

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

Kopin

SEALSQ

Maxeon Solar Technologies, Ltd. - Ordinary Shares

Maxeon Solar Technologies

Mobix Labs

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

Nano Labs

Pixelworks

QuickLogic

Rigetti Computing, Inc. - Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

Rigetti Computing

Semilux International Ltd. - Ordinary Shares

Semilux International

SkyWater Technology

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Intchains Gr

Actualités

Dernières nouvelles pour Intchains Gr (NASDAQ:ICG) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL